Adding to a flurry of activity around cell and regenerative therapies in Japan over the past few months, local venture Healios KK has begun recruiting for a clinical trial with a novel cell therapy for acute respiratory distress syndrome (ARDS).
Japan's Healios Progresses Novel Cell Therapy For ARDS
Activity in Japan's cell and regenerative therapy space continues apace as venture starts trial with lead development asset for acute respiratory distress syndrome.
